These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 21410354)

  • 1. Detection of Epstein-Barr virus DNA in serum or plasma for nasopharyngeal cancer: a meta-analysis.
    Liu Y; Fang Z; Liu L; Yang S; Zhang L
    Genet Test Mol Biomarkers; 2011; 15(7-8):495-502. PubMed ID: 21410354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of Epstein-Barr virus DNA in plasma/serum: a useful serological indicator for diagnosis of nasopharyngeal carcinoma.
    Mai S; Zong Y; Zhang M; Zhong B; Lin S
    Chin Med J (Engl); 2002 Dec; 115(12):1895-7. PubMed ID: 12622949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical value of a plasma Epstein-Barr virus DNA assay in the diagnosis of recurrent or metastatic nasopharyngeal carcinoma: a meta-analysis.
    Peng H; Li Z; Long Y; Li J; Liu Z; Zhou R
    Biosci Rep; 2019 Sep; 39(9):. PubMed ID: 31484795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Significance of cell-free Epstein-Barr virus DNA in monitoring prognosis of nasopharyngeal carcinoma].
    Cao SM; Min HQ; Gao JS; Hong MH; Xiao XB; Zhang CQ; Liu XD; Zhang AL; Guo X
    Ai Zheng; 2003 Mar; 22(3):302-6. PubMed ID: 12654192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic review on Epstein-Barr virus (EBV) DNA in diagnosis of nasopharyngeal carcinoma in Asian populations.
    Han BL; Xu XY; Zhang CZ; Wu JJ; Han CF; Wang H; Wang X; Wang GS; Yang SJ; Xie Y
    Asian Pac J Cancer Prev; 2012; 13(6):2577-81. PubMed ID: 22938423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Epstein-Barr virus DNA level in plasma, peripheral blood cell and tumor tissue in nasopharyngeal carcinoma.
    Shao JY; Zhang Y; Li YH; Gao HY; Feng HX; Wu QL; Cui NJ; Cheng G; Hu B; Hu LF; Ernberg I; Zeng YX
    Anticancer Res; 2004; 24(6):4059-66. PubMed ID: 15736452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early detection of nasopharyngeal carcinoma by plasma Epstein-Barr virus DNA analysis in a surveillance program.
    Chan KC; Hung EC; Woo JK; Chan PK; Leung SF; Lai FP; Cheng AS; Yeung SW; Chan YW; Tsui TK; Kwok JS; King AD; Chan AT; van Hasselt AC; Lo YM
    Cancer; 2013 May; 119(10):1838-44. PubMed ID: 23436393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of circulating plasma/serum EBV DNA in the clinical management of nasopharyngeal carcinoma.
    Yip TT; Ngan RK; Fong AH; Law SC
    Oral Oncol; 2014 Jun; 50(6):527-38. PubMed ID: 24440146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical value of serum Epstein-Barr virus DNA assay in the diagnosis of nasopharyngeal carcinoma.
    Sun D; Yang Z; Fu Y; Chen Y; Wang S; Zhang Y; Ma Y; Zhang X
    Tumour Biol; 2014 Sep; 35(9):8787-93. PubMed ID: 24879626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-Barr virus DNA in serum/plasma as a tumor marker for nasopharyngeal cancer.
    Shotelersuk K; Khorprasert C; Sakdikul S; Pornthanakasem W; Voravud N; Mutirangura A
    Clin Cancer Res; 2000 Mar; 6(3):1046-51. PubMed ID: 10741733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of plasma Epstein-Barr virus (EBV) DNA levels and serum EBV immunoglobulin A/virus capsid antigen antibody titers in patients with nasopharyngeal carcinoma.
    Shao JY; Li YH; Gao HY; Wu QL; Cui NJ; Zhang L; Cheng G; Hu LF; Ernberg I; Zeng YX
    Cancer; 2004 Mar; 100(6):1162-70. PubMed ID: 15022282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Real-time quantitative PCR assay of Epstein-Barr virus in whole blood cells of nasopharyngeal carcinoma patients].
    Wang H; Deng L; Chen SH; Wang SQ; Cao Y
    Shi Yan Sheng Wu Xue Bao; 2003 Feb; 36(1):32-6. PubMed ID: 12751207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pretherapy quantitative measurement of circulating Epstein-Barr virus DNA is predictive of posttherapy distant failure in patients with early-stage nasopharyngeal carcinoma of undifferentiated type.
    Leung SF; Chan AT; Zee B; Ma B; Chan LY; Johnson PJ; Lo YM
    Cancer; 2003 Jul; 98(2):288-91. PubMed ID: 12872347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined determination of Epstein-Barr virus-related antibodies and antigens for diagnosis of nasopharyngeal carcinoma.
    Luo YL; Ou GP; Chi PD; Liang YN; Liu YH; Huang MY
    Ai Zheng; 2009 Jan; 28(1):76-8. PubMed ID: 19448423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma Epstein-Barr virus (EBV) DNA: role as a screening test for nasopharyngeal carcinoma (NPC)?
    Wong LP; Lai KT; Tsui E; Kwong KH; Tsang RH; Ma ES
    Int J Cancer; 2005 Nov; 117(3):515-6. PubMed ID: 15906350
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of clinical and molecular surveillance in patients with advanced nasopharyngeal carcinoma after primary therapy: the potential role of quantitative analysis of circulating Epstein-Barr virus DNA.
    Hong RL; Lin CY; Ting LL; Ko JY; Hsu MM
    Cancer; 2004 Apr; 100(7):1429-37. PubMed ID: 15042677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Telomerase assay and nested polymerase chain reaction from nasopharyngeal swabs for early noninvasive detection of nasopharyngeal carcinoma.
    Kerekhanjanarong V; Sitawarin S; Sakdikul S; Saengpanich S; Chindavijak S; Supiyaphun P; Voravud N; Mutirangura A
    Otolaryngol Head Neck Surg; 2000 Nov; 123(5):624-9. PubMed ID: 11077353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus detection in nasopharyngeal tissues of patients with suspected nasopharyngeal carcinoma.
    Tsai ST; Jin YT; Mann RB; Ambinder RF
    Cancer; 1998 Apr; 82(8):1449-53. PubMed ID: 9554519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Epstein-Barr virus DNA measurement in plasma in the clinical management of nasopharyngeal carcinoma in a low risk area.
    Kalpoe JS; Dekker PB; van Krieken JH; Baatenburg de Jong RJ; Kroes AC
    J Clin Pathol; 2006 May; 59(5):537-41. PubMed ID: 16489178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of plasma Epstein-Barr virus DNA load as a prognostic marker for nasopharyngeal carcinoma.
    Tan EL; Looi LM; Sam CK
    Singapore Med J; 2006 Sep; 47(9):803-7. PubMed ID: 16924363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.